Darbepoetin alfaErythropoiesis-Stimulating Agent (Erythropoiesis-Stimulating Agent) Indication: Treatment of anemia due to:• Chronic Kidney Disease (CKD) in patients on dialysis and patients not on dialysis• The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy Dosage & Administration: Recommended starting dose for patients with CKD on […]